Recombinant hf-SCIg in inflammatory myositis: refining patient selection and outcome assessment. Author's reply

Giacomo Emmi1, Adalgisa Palermo2, Maria Letizia Urban3

  • 1Department of Medical, Surgery and Health Sciences, University of Trieste, Italy and Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; Department of Medicine, Centre for Inflammatory Diseases, Monash Medical Centre, Monash University, Melbourne, Victoria, Australia.

PubMed
Abstract

No abstract available in PubMed .